Clinical Trial Update: Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intravenous prostaglandins for ischemic optic neuropathy is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Optic Neuropathy

Drugs mentioned

• Prostaglandins (intravenous infusion)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Ischemic Optic Neuropathy | Phase 2 | Status: UNKNOWN